Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating a user interface presentation using a life sciences research platform. In one aspect, a method includes: receiving input data for multiple life sciences experiments within a research domain, where input data includes a collection of experimental settings for the life sciences experiments, automatically generating multiple machine learning models for the research domain, where each machine learning model predicts a value for an experimental outcome metric, automatically selecting a final machine learning model within the research domain based on performance measures, and generating a user interface presentation of explainability data that explains a contribution of each setting in a collection of settings to the value for the experimental outcome metric predicted by the final machine learning model.

Abstract: Methods, computer-readable media, systems and apparatuses for receiving data from one or more sensors associated with one or more home devices for a plurality of homes relating to one or more possible perils such as water perils.

Abstract: Methods, computer-readable media, systems and apparatuses for home services and for completing various home services are provided. Based on received information, the system may generate a services list for the home, provide products and service providers for completion of the services, and provide clickable links to experts for advice to complete the services. Data related to services performed on the home may be received and, based on the received services data, a determination may be made as to whether one or more services on the services list have been completed.

Abstract: The invention relates to combinations comprising a vascular disrupting agent (VDA) with IAP antagonists, for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of proliferative diseases.

Abstract: A predictive indicator tool for predicting the risk of a manufacturing process producing products having defects. Manufacturing sub-processes are identified for the process and s a series of 12 questions is applied to each sub-process. The questions are generated using Six Sigma statistical techniques. The questions are scored and an associated algorithm is applied to produce a quantitative score is indicative of risk. The quantitative risk score is compared to an alert level.

Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein Z, R1, R2a, R2b, R10, R11 and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

Abstract: The present invention provides a human embryo co-culture system comprising a suspension of cultured human tubal epithelial cells. Also provided is a method of method of improving the pregnancy rate of a female undergoing in vitro fertilization, comprising the steps of: contacting an oocyte from said female with a monolayer of cultured human tubal epithelial cells; inseminating the oocyte; and transferring an embryo back to said female.